← Back to Search

Discharge Antibiotic Stewardship for Pediatric Infections (DISCO Trial)

N/A
Waitlist Available
Led By Jeffrey S Gerber, MD, PhD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Patient: Subjects >18 years of age, hospital length of stay >7 days, requiring intensive care unit level of care
Clinician: <18 years old, not employed by the hospital
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if a discharge stewardship bundle can reduce inappropriate antibiotic prescribing for kids with 3 common infections. It will involve surveys, interviews and feedback reports.

Who is the study for?
This trial is for children under 18 with common infections like pneumonia, UTIs, or skin infections who are being discharged from the hospital. It's also for their parents and healthcare providers over 18 working at the hospital. Children who stayed in the hospital longer than a week or needed intensive care are not eligible.
What is being tested?
The study tests a 'discharge stewardship bundle' to see if it helps reduce unnecessary antibiotic prescriptions when kids leave the hospital after treatment for pneumonia, UTI, or skin infections. The intervention will be adapted and implemented across four children's hospitals.
What are the potential side effects?
Since this trial focuses on improving antibiotic prescribing practices rather than testing new medications, side effects are not a primary concern of this study. However, antibiotics can typically cause digestive issues or allergic reactions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am over 18, have been in the hospital for more than 7 days, and need intensive care.
Select...
I am under 18 and do not work for the hospital.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of suboptimal prescribing
Secondary study objectives
Impact of the discharge stewardship intervention on adverse drug events
Impact of the discharge stewardship intervention on post-discharge treatment failure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pediatric HospitalistsExperimental Treatment1 Intervention
Prescribing physicians and hospital employees will be recruited during regularly held staff meetings prior to the data collection period. The study team will briefly introduce the study aims and methods and let the hospitalists know that the study team will be emailing them separately to ask permission for Dr. Szymczak to shadow them. Only those who have agreed will participate in the ethnographic observations. For the interviews and surveys, the study team will recruit respondents via contact made during ethnographic observations. The study team will also utilize a snowball approach by asking respondents if they know of any other staff who might be interested in participating in an interview. Approximately 120 clinicians will participate in the interviews and surveys.
Group II: Families of hospitalized childrenActive Control1 Intervention
Families of children who were hospitalized at one of the four participating sites will be approached for consent to participate in the study. Families who consent will complete 2 brief REDCap surveys and a wellness tracker after their child is discharged from the hospital.

Find a Location

Who is running the clinical trial?

Agency for Healthcare Research and Quality (AHRQ)FED
406 Previous Clinical Trials
6,751,491 Total Patients Enrolled
5 Trials studying Pneumonia
919,618 Patients Enrolled for Pneumonia
Children's Hospital of PhiladelphiaLead Sponsor
731 Previous Clinical Trials
8,467,320 Total Patients Enrolled
3 Trials studying Pneumonia
15,175 Patients Enrolled for Pneumonia
Seattle Children's HospitalOTHER
310 Previous Clinical Trials
5,225,510 Total Patients Enrolled
Primary Children's HospitalOTHER
21 Previous Clinical Trials
14,740 Total Patients Enrolled
St. Louis Children's HospitalOTHER
29 Previous Clinical Trials
82,102 Total Patients Enrolled
University of PennsylvaniaOTHER
2,082 Previous Clinical Trials
42,721,610 Total Patients Enrolled
9 Trials studying Pneumonia
5,704 Patients Enrolled for Pneumonia
Jeffrey S Gerber, MD, PhDPrincipal InvestigatorAssociate Professor, Pediatrics
3 Previous Clinical Trials
3,151 Total Patients Enrolled
1 Trials studying Pneumonia
170 Patients Enrolled for Pneumonia

Media Library

Discharge antibiotic stewardship intervention Clinical Trial Eligibility Overview. Trial Name: NCT05826873 — N/A
Pneumonia Research Study Groups: Families of hospitalized children, Pediatric Hospitalists
Pneumonia Clinical Trial 2023: Discharge antibiotic stewardship intervention Highlights & Side Effects. Trial Name: NCT05826873 — N/A
Discharge antibiotic stewardship intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05826873 — N/A
~0 spots leftby Jan 2025